Characterisation of tumour variants of Devil Facial Tumour Disease. This project will take a new approach to cancer research by studying the evolution of Devil Facial Tumour Disease. The results will directly contribute to the conservation management of the Tasmanian devil, as well as generating new information on tumour growth, metastasis and emergence of resistance.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE160100204
Funder
Australian Research Council
Funding Amount
$550,000.00
Summary
A systems biology capability for the Ramaciotti Centre for Genomics. A systems biology capability for the Ramaciotti Centre for Genomics:
The project aims to introduce a complete systems biology capability to the Ramaciotti Centre for Genomics. This is intended to provide a complete systems biology workflow, including improved data analysis for next-generation sequencing, tissue preparation and imaging, and mass spectrometry for proteomics and metabolomics. This would enable a truly systems app ....A systems biology capability for the Ramaciotti Centre for Genomics. A systems biology capability for the Ramaciotti Centre for Genomics:
The project aims to introduce a complete systems biology capability to the Ramaciotti Centre for Genomics. This is intended to provide a complete systems biology workflow, including improved data analysis for next-generation sequencing, tissue preparation and imaging, and mass spectrometry for proteomics and metabolomics. This would enable a truly systems approach to biological problems, supporting researchers and projects that focus on microbial and mammalian metabolism, carbohydrate chemistry and synthetic biology. Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE170100032
Funder
Australian Research Council
Funding Amount
$900,000.00
Summary
Access to the National Computing Infrastructure peak supercomputing facility. This project aims to continue the access of Intersect’s computational researchers to the National Computational Infrastructure (NCI) peak supercomputing facility. The peak supercomputing facility at NCI is critical collaborative infrastructure on a globally competitive scale. Transformative advances in science and technology increasingly rely on high performance computing capabilities across a wide range of research di ....Access to the National Computing Infrastructure peak supercomputing facility. This project aims to continue the access of Intersect’s computational researchers to the National Computational Infrastructure (NCI) peak supercomputing facility. The peak supercomputing facility at NCI is critical collaborative infrastructure on a globally competitive scale. Transformative advances in science and technology increasingly rely on high performance computing capabilities across a wide range of research disciplines. Ongoing access to this facility will allow researchers to tackle major problems in national priority areas including energy, health, and environmental change.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE170100506
Funder
Australian Research Council
Funding Amount
$372,000.00
Summary
Specialised ribosomes: An unexplored regulatory layer to tune the proteome. This project aims to decipher human ribosome composition across tissues and conditions, and regulate its composition and activity (selective translation of subsets of transcripts) in a tissue-dependent, spatial and temporal manner – a major challenge in biology. Although ribosomes have been historically thought of as uniform entities, recent evidence suggests that their composition might be regulated. Elevating the expre ....Specialised ribosomes: An unexplored regulatory layer to tune the proteome. This project aims to decipher human ribosome composition across tissues and conditions, and regulate its composition and activity (selective translation of subsets of transcripts) in a tissue-dependent, spatial and temporal manner – a major challenge in biology. Although ribosomes have been historically thought of as uniform entities, recent evidence suggests that their composition might be regulated. Elevating the expression of a target protein without affecting mRNA levels is expected to benefit other disciplines, including biotechnology (e.g. recombinant protein expression), biomedicine (e.g. treatment of a human disease by suppression or enhancement of the levels of key disease-related proteins) and synthetic biology.Read moreRead less
Deciphering The Role Of Atypical DNA Methylation In Neuronal Genome Regulation And Neurological Disorders
Funder
National Health and Medical Research Council
Funding Amount
$773,484.00
Summary
This research will use a combination of genomic, biochemical and functional genomics approaches to investigate the role of the atypical mCH form of DNA methylation in neuronal genome regulation and function, and provide new insights into the role of the epigenome in healthy brain function and neural pathologies.
The Economic And Social Impacts Of Genetic Sequencing For Intellectual Disability
Funder
National Health and Medical Research Council
Funding Amount
$1,263,576.00
Summary
In this project we will quantify the social and financial costs to families of severe intellectual disability that is genetic in origin. We will assess these impacts in terms of poorer carer health, relationship breakdown, lost income and risk of poverty, as well as increased dependence on government, particularly on welfare payments, and reduced personal income tax paid. We will then determine the extent to which modern clinical genomics can contribute to ameliorating these impacts.
Understanding The Role Of RAS Mutations In Thyroid Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$463,854.00
Summary
My fellowship will examine the association of RAS mutations in thyroid cancer. RAS proteins are the most mutated in cancer and I will investigate how they work in thyroid cancer. RAS mutated thyroid cancer is more likely to cause death. This grant will be based in the pioneering lab of Prof Fagin at Memorial Sloan Kettering Cancer Center and the Garvan Institute of Medical Research. It is hoped by understanding these mutations, new treatments for thyroid cancer can be developed.
Genomic Analysis Of DNA Binding And Gene Regulation By The Chromatin Remodelling Factor UBF
Funder
National Health and Medical Research Council
Funding Amount
$624,254.00
Summary
Synthesis of ribosomes, the cellular protein synthetic machinery, is the major anabolic event of a growing cell and is frequently dysregulated during disease such as cancer. This grant will examine a protein termed UBF that we think plays an important role in orchestrating the cellular response to dysregulated ribosome biogenesis. By understanding how UBF functions we hope to uncover novel therapeutic approaches to treat diseases associated with ribosome stress .
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE140100114
Funder
Australian Research Council
Funding Amount
$560,000.00
Summary
High Throughput Cell Genomics Centre. High throughput cell genomics centre: This project will establish a high throughput cell genomics centre comprising a Fluidigm C1™ Single-Cell AutoPrep and BioMark™ HD system providing researchers with the most innovative approach to single cell and small population analyses. The instruments will enable the unique capability to conduct single cell transcriptome analysis and high throughput gene expression, SNP genotyping and copy number variation analysis as ....High Throughput Cell Genomics Centre. High throughput cell genomics centre: This project will establish a high throughput cell genomics centre comprising a Fluidigm C1™ Single-Cell AutoPrep and BioMark™ HD system providing researchers with the most innovative approach to single cell and small population analyses. The instruments will enable the unique capability to conduct single cell transcriptome analysis and high throughput gene expression, SNP genotyping and copy number variation analysis as well as validation of next generation sequencing data. The information generated is crucial to advancing knowledge in important research fields including infection and immunity, regenerative medicine, immune responses, biomarker discovery, drug discovery, biotechnology and agriculture.Read moreRead less